347 related articles for article (PubMed ID: 28770703)
1. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703
[TBL] [Abstract][Full Text] [Related]
2. Human anti-alpha-enolase antibody in sera from patients with Behçet's disease and rheumatologic disorders.
Lee JH; Cho SB; Bang D; Oh SH; Ahn KJ; Kim J; Park YB; Lee SK; Lee KH
Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S63-6. PubMed ID: 19796536
[TBL] [Abstract][Full Text] [Related]
3. Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease.
Lee KH; Chung HS; Kim HS; Oh SH; Ha MK; Baik JH; Lee S; Bang D
Arthritis Rheum; 2003 Jul; 48(7):2025-35. PubMed ID: 12847697
[TBL] [Abstract][Full Text] [Related]
4. Anti-alpha-enolase antibodies in Behçet's disease: a marker of mucocutaneous and articular disease activity?
Prado LL; Goncalves CR; Viana VT; Saad CGS; Bonfa E
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):28-32. PubMed ID: 29465373
[TBL] [Abstract][Full Text] [Related]
5. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
6. Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet's Disease.
Novak T; Hamedi M; Bergmeier LA; Fortune F; Hagi-Pavli E
Front Immunol; 2021; 12():724900. PubMed ID: 35003055
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
[TBL] [Abstract][Full Text] [Related]
8. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
9. Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations.
Lucherini OM; Vitale A; Orlando I; Sota J; Fabiani C; Franceschini R; Simpatico A; Frediani B; Galeazzi M; Tosi GM; Cantarini L
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):110-115. PubMed ID: 30582507
[TBL] [Abstract][Full Text] [Related]
10. Serum anti-lysozyme is associated with disease activity of Behçet's disease.
Park JS; Kang MI; Ha YJ; Song JJ; Park YB; Lee SK; Lee SW
Int J Rheum Dis; 2017 Feb; 20(2):261-268. PubMed ID: 26890818
[TBL] [Abstract][Full Text] [Related]
11. Circulating immune complexome analysis identified anti-tubulin-α-1c as an inflammation associated autoantibody with promising diagnostic value for Behcet's Disease.
Cheng Y; Zhao X; Chen Y; Li Y; Jia R; Zhu L; Huang C; Sun X; Deng H; Li Z
PLoS One; 2018; 13(6):e0199047. PubMed ID: 29902281
[TBL] [Abstract][Full Text] [Related]
12. Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet's disease.
Jung YS; Kim SW; Yoon JY; Lee JH; Jeon SM; Hong SP; Kim TI; Kim WH; Cheon JH
Inflamm Bowel Dis; 2011 Oct; 17(10):2130-7. PubMed ID: 21910175
[TBL] [Abstract][Full Text] [Related]
13. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
14. Anti-alpha-enolase antibody as a serologic marker and its correlation with disease severity in intestinal Behçet's disease.
Shin SJ; Kim BC; Kim TI; Lee SK; Lee KH; Kim WH
Dig Dis Sci; 2011 Mar; 56(3):812-8. PubMed ID: 20632102
[TBL] [Abstract][Full Text] [Related]
15. Identification of streptococcal proteins reacting with sera from Behçet's disease and rheumatic disorders.
Cho SB; Lee JH; Ahn KJ; Cho S; Park YB; Lee SK; Bang D; Lee KH
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S31-8. PubMed ID: 20868568
[TBL] [Abstract][Full Text] [Related]
16. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of alpha-1 acid glycoprotein and pentraxin 3 in patients with Behçet's disease and relationship with disease activity.
Yazmalar L; Batmaz İ; Sula B; Alpaycı M; Aydın F; Türkçü F; Yıldız M; Kaplan İ; Bozkurt M; Dağlı AZ; Burkan YK; Sarıyıldız MA
Int J Dermatol; 2015 Oct; 54(10):e394-400. PubMed ID: 26147939
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
[TBL] [Abstract][Full Text] [Related]
19. Serum GDF-15 level in Behçet's disease: relationships between disease activity and clinical parameters.
Sarıyıldız MA; Yazmalar L; Batmaz İ; Alpaycı M; Burkan YK; Sula B; Kaplan İ; Yıldız M; Akar ZA; Bozkurt M
Int J Dermatol; 2016 Nov; 55(11):1289-1294. PubMed ID: 27206990
[TBL] [Abstract][Full Text] [Related]
20. Streptococcus sanguinis and the sera of patients with Behçet's disease stimulate membrane expression of α-enolase in human dermal microvascular endothelial cells.
Cho S; Zheng Z; Cho SB; Choi MJ; Lee KH; Bang D
Arch Dermatol Res; 2013 Apr; 305(3):223-32. PubMed ID: 23131860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]